News

Association of Healthcare Social Media meeting on hold until spring 2021

After initially postponing the meeting until later this year, organizers of the Association of Healthcare Social Media meeting have decided to cancel the meeting in 2020, pushing their inaugural gathering to 2021.Originally scheduled to take place in Philadelphia on May 30, the AHSM was intended to guide physicians through the best practices and issues surrounding…

News

FDA grants breakthrough therapy designation to Enhertu for gastric cancer subset

The FDA granted breakthrough therapy designation to fam-trastuzumab deruxtecan-nxki for treatment of patients with HER2-positive unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma.The designation applies to use of fam-trastuzumab deruxtecan-nxki (Enhertu; AstraZeneca, Daiichi Sankyo) by patients who received two or more prior regimens, including trastuzumab (Herceptin, Genentech).Fam-trastuzumab deruxtecan-nxki is a novel antibody-drug conjugate with three…

News

Relistor reduces mortality in patients with opioid-induced constipation

In this exclusive video, Lynn R. Webster, MD, from PRA Health Sciences in Salt Lake City, discusses his study from Digestive Disease Week that explored the impact of Relistor, a mu-opioid receptor agonist, on all-cause mortality in patients with opioid-induced constipation.In a retrospective analysis of 11 phase 2 and 3 randomized controlled trials, researchers found…

News

Artificial Intelligence transforms search for COVID-19 vaccines, cure

Developers are using artificial intelligence to help researchers comb through thousands of studies and find relevant COVID-19 information for the development of potential treatments and vaccines.For example, a team at Lawrence Berkeley National Laboratory in California built covidscholar.org, a publicly available model that provides “research that’s relevant to the work researchers are doing and helps…